ProQR Therapeutics N.V.
PRQR
$1.47
-$0.06-3.92%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | -15.36M | -10.38M | -12.87M | -13.82M | -10.61M |
| Total Depreciation and Amortization | 796.40K | 790.40K | 784.50K | 766.10K | 713.50K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 1.65M | 1.54M | 1.37M | 1.45M | 341.00K |
| Change in Net Operating Assets | 125.10K | -7.50M | -3.59M | -1.34M | -7.07M |
| Cash from Operations | -12.79M | -15.55M | -14.30M | -12.94M | -16.63M |
| Capital Expenditure | -188.20K | -612.30K | -197.60K | -114.60K | -235.70K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -188.20K | -612.30K | -197.60K | -114.60K | -235.70K |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -304.00K | -601.00K | -444.00K | -293.00K | -567.00K |
| Issuance of Common Stock | -- | 2.00K | -- | -- | 67.00K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -348.90K | -697.30K | -519.10K | -332.50K | -526.20K |
| Foreign Exchange rate Adjustments | 330.50K | 14.00K | -39.80K | -969.20K | -496.70K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -13.00M | -16.84M | -15.06M | -14.36M | -17.88M |